Mick Hitchcock

Interim CEO @ Biomea Fusion

About

I am biochemist/microbiologist with 40+ years of experience in development of pharmaceuticals, with a particular emphasis on antiviral drugs. I have a number of areas in which I make a periodic contribution University of Nevada, Reno Foundation Trustee Adjunct Professor, Dept. Microbiol. & Immunol., UNR School of Medicine Advisory Council Member, UNR College of Science Advisory Council Member, UNR College of Business Board Member, Strykagen

Country

United States

City

Reno

Industry

Biotechnology

Skill

Biotechnology, Pharmaceutical Industry, Lifesciences, Clinical Development, Clinical Trials, Infectious Diseases, Technology Transfer, Drug Development, Regulatory Affairs, Biopharmaceuticals, FDA, Strategy, Enzyme Assays, Protein Purification, Life Sciences

Experience

Interim CEO

Biomea Fusion

2025-3 - Present · 1 yr 7 mos

United States

Member Board Of Directors

Biomea Fusion

2021-3 - 2025-3 · 4 yrs 1 mo

San Carlos, California, United States

Member Board Of Trustees

American Council on Science and Health

2022-7 - Present · 4 yrs 3 mos

Non Executive Chairman

RENOGENYX

2020-10 - Present · 6 yrs

Reno, Nevada, United States

www.renogenyx.com

Chair Of The Board Of Trustees

UNIVERSITY OF NEVADA RENO FOUNDATION

2020-1 - 2020-12 · 1 yr

Reno, Nevada Area

Senior Advisor

Gilead Sciences

2009-5 - 2019-11 · 10 yrs 7 mos

Provide input on Portfolio & Projects, review scientific data, assess opportunities, mentor others, etc.

Various

Gilead Sciences

1993-1 - 2009-5 · 16 yrs 5 mos

DIrector, Project Planning & Management

Bristol Myers Squibb

1990-10 - 1993-1 · 2 yrs 4 mos

Wallingford, Connecticut, United States

Responsible for Anti-Infective Porfolio of 9 projects. Provided integrated management of projects across multi-disciplinary departments to allow successful development of products for antiviral, antifungal and antibacterial uses.